Unfortunately, it's not necessarily all good news
Adverse events such as diarrhea, constipation, nausea, and vomiting associated with the GLP-1 RAs overlap with those seen with cancer treatments, so the patient who is undergoing treatment with an emetogenic regimen for cancer will likely experience additional weight loss, which can lead to nutritional deficiencies, loss of lean muscle mass, and loss of bone mass
Por s sola, sin cambios en la dieta y la actividad fsica, no produce una reduccin significativa de peso o grasa corporal
A diagnosis code alone may not be sufficient
This product has not intended to diagnose, treat, cure, or prevent any disease
During the Weight Loss Program, you will receive personalized diet plans, exercise routines, and behavioral strategies